
Molecular cloning service is a biotechnology service that aims to insert the target gene into a cloning vector through in vitro recombination methods to form a recombinant cloning vector, and replicate and amplify it in an appropriate host. In molecular cloning services, customers usually need to provide original samples, information about the target gene, and experimental requirements. The service provider is responsible for completing the entire molecular cloning process and providing high-quality clone products. These products can be used for subsequent gene function research, protein expression, virus packaging, cell therapy, mRNA vaccines and other applications.
The global Molecular Cloning Technology Services market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Molecular Cloning Technology Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Molecular Cloning Technology Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Molecular Cloning Technology Services in Laboratory is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Molecular Cloning Technology Services include VectorBuilder, BioServUK, GenScript, urofins Genomics, Innoprot, Genewiz, Bio-Fab Research, OriGene, Prospec-Tany Technogene, Addgene, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Molecular Cloning Technology Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Cloning Technology Services.
The Molecular Cloning Technology Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Molecular Cloning Technology Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Molecular Cloning Technology Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
VectorBuilder
BioServUK
GenScript
urofins Genomics
Innoprot
Genewiz
Bio-Fab Research
OriGene
Prospec-Tany Technogene
Addgene
Protein Ark
Protomnis
RD-Biotech
Charles River
Segment by Type
Restriction Enzyme Cloning
Primer Amplification Cloning
Gene Library Cloning
Gene Mutation Cloning
Genomic Cloning
Segment by Application
Laboratory
Research Institute
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Molecular Cloning Technology Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Molecular Cloning Technology Services 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Restriction Enzyme Cloning
1.2.3 Primer Amplification Cloning
1.2.4 Gene Library Cloning
1.2.5 Gene Mutation Cloning
1.2.6 Genomic Cloning
1.3 麻豆原创 by Application
1.3.1 Global Molecular Cloning Technology Services 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Laboratory
1.3.3 Research Institute
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Molecular Cloning Technology Services 麻豆原创 Perspective (2019-2030)
2.2 Global Molecular Cloning Technology Services Growth Trends by Region
2.2.1 Global Molecular Cloning Technology Services 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Molecular Cloning Technology Services Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Molecular Cloning Technology Services Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Molecular Cloning Technology Services 麻豆原创 Dynamics
2.3.1 Molecular Cloning Technology Services Industry Trends
2.3.2 Molecular Cloning Technology Services 麻豆原创 Drivers
2.3.3 Molecular Cloning Technology Services 麻豆原创 Challenges
2.3.4 Molecular Cloning Technology Services 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Cloning Technology Services Players by Revenue
3.1.1 Global Top Molecular Cloning Technology Services Players by Revenue (2019-2024)
3.1.2 Global Molecular Cloning Technology Services Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Molecular Cloning Technology Services 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Molecular Cloning Technology Services Revenue
3.4 Global Molecular Cloning Technology Services 麻豆原创 Concentration Ratio
3.4.1 Global Molecular Cloning Technology Services 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Cloning Technology Services Revenue in 2023
3.5 Global Key Players of Molecular Cloning Technology Services Head office and Area Served
3.6 Global Key Players of Molecular Cloning Technology Services, Product and Application
3.7 Global Key Players of Molecular Cloning Technology Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Cloning Technology Services Breakdown Data by Type
4.1 Global Molecular Cloning Technology Services Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Molecular Cloning Technology Services Forecasted 麻豆原创 Size by Type (2025-2030)
5 Molecular Cloning Technology Services Breakdown Data by Application
5.1 Global Molecular Cloning Technology Services Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Molecular Cloning Technology Services Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Molecular Cloning Technology Services 麻豆原创 Size (2019-2030)
6.2 North America Molecular Cloning Technology Services 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Molecular Cloning Technology Services 麻豆原创 Size by Country (2019-2024)
6.4 North America Molecular Cloning Technology Services 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Molecular Cloning Technology Services 麻豆原创 Size (2019-2030)
7.2 Europe Molecular Cloning Technology Services 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Molecular Cloning Technology Services 麻豆原创 Size by Country (2019-2024)
7.4 Europe Molecular Cloning Technology Services 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Molecular Cloning Technology Services 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Molecular Cloning Technology Services 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Molecular Cloning Technology Services 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Molecular Cloning Technology Services 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Molecular Cloning Technology Services 麻豆原创 Size (2019-2030)
9.2 Latin America Molecular Cloning Technology Services 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Molecular Cloning Technology Services 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Molecular Cloning Technology Services 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Cloning Technology Services 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Molecular Cloning Technology Services 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Molecular Cloning Technology Services 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Molecular Cloning Technology Services 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 VectorBuilder
11.1.1 VectorBuilder Company Details
11.1.2 VectorBuilder Business Overview
11.1.3 VectorBuilder Molecular Cloning Technology Services Introduction
11.1.4 VectorBuilder Revenue in Molecular Cloning Technology Services Business (2019-2024)
11.1.5 VectorBuilder Recent Development
11.2 BioServUK
11.2.1 BioServUK Company Details
11.2.2 BioServUK Business Overview
11.2.3 BioServUK Molecular Cloning Technology Services Introduction
11.2.4 BioServUK Revenue in Molecular Cloning Technology Services Business (2019-2024)
11.2.5 BioServUK Recent Development
11.3 GenScript
11.3.1 GenScript Company Details
11.3.2 GenScript Business Overview
11.3.3 GenScript Molecular Cloning Technology Services Introduction
11.3.4 GenScript Revenue in Molecular Cloning Technology Services Business (2019-2024)
11.3.5 GenScript Recent Development
11.4 urofins Genomics
11.4.1 urofins Genomics Company Details
11.4.2 urofins Genomics Business Overview
11.4.3 urofins Genomics Molecular Cloning Technology Services Introduction
11.4.4 urofins Genomics Revenue in Molecular Cloning Technology Services Business (2019-2024)
11.4.5 urofins Genomics Recent Development
11.5 Innoprot
11.5.1 Innoprot Company Details
11.5.2 Innoprot Business Overview
11.5.3 Innoprot Molecular Cloning Technology Services Introduction
11.5.4 Innoprot Revenue in Molecular Cloning Technology Services Business (2019-2024)
11.5.5 Innoprot Recent Development
11.6 Genewiz
11.6.1 Genewiz Company Details
11.6.2 Genewiz Business Overview
11.6.3 Genewiz Molecular Cloning Technology Services Introduction
11.6.4 Genewiz Revenue in Molecular Cloning Technology Services Business (2019-2024)
11.6.5 Genewiz Recent Development
11.7 Bio-Fab Research
11.7.1 Bio-Fab Research Company Details
11.7.2 Bio-Fab Research Business Overview
11.7.3 Bio-Fab Research Molecular Cloning Technology Services Introduction
11.7.4 Bio-Fab Research Revenue in Molecular Cloning Technology Services Business (2019-2024)
11.7.5 Bio-Fab Research Recent Development
11.8 OriGene
11.8.1 OriGene Company Details
11.8.2 OriGene Business Overview
11.8.3 OriGene Molecular Cloning Technology Services Introduction
11.8.4 OriGene Revenue in Molecular Cloning Technology Services Business (2019-2024)
11.8.5 OriGene Recent Development
11.9 Prospec-Tany Technogene
11.9.1 Prospec-Tany Technogene Company Details
11.9.2 Prospec-Tany Technogene Business Overview
11.9.3 Prospec-Tany Technogene Molecular Cloning Technology Services Introduction
11.9.4 Prospec-Tany Technogene Revenue in Molecular Cloning Technology Services Business (2019-2024)
11.9.5 Prospec-Tany Technogene Recent Development
11.10 Addgene
11.10.1 Addgene Company Details
11.10.2 Addgene Business Overview
11.10.3 Addgene Molecular Cloning Technology Services Introduction
11.10.4 Addgene Revenue in Molecular Cloning Technology Services Business (2019-2024)
11.10.5 Addgene Recent Development
11.11 Protein Ark
11.11.1 Protein Ark Company Details
11.11.2 Protein Ark Business Overview
11.11.3 Protein Ark Molecular Cloning Technology Services Introduction
11.11.4 Protein Ark Revenue in Molecular Cloning Technology Services Business (2019-2024)
11.11.5 Protein Ark Recent Development
11.12 Protomnis
11.12.1 Protomnis Company Details
11.12.2 Protomnis Business Overview
11.12.3 Protomnis Molecular Cloning Technology Services Introduction
11.12.4 Protomnis Revenue in Molecular Cloning Technology Services Business (2019-2024)
11.12.5 Protomnis Recent Development
11.13 RD-Biotech
11.13.1 RD-Biotech Company Details
11.13.2 RD-Biotech Business Overview
11.13.3 RD-Biotech Molecular Cloning Technology Services Introduction
11.13.4 RD-Biotech Revenue in Molecular Cloning Technology Services Business (2019-2024)
11.13.5 RD-Biotech Recent Development
11.14 Charles River
11.14.1 Charles River Company Details
11.14.2 Charles River Business Overview
11.14.3 Charles River Molecular Cloning Technology Services Introduction
11.14.4 Charles River Revenue in Molecular Cloning Technology Services Business (2019-2024)
11.14.5 Charles River Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 麻豆原创 Size Estimation
13.1.1.3 麻豆原创 Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
VectorBuilder
BioServUK
GenScript
urofins Genomics
Innoprot
Genewiz
Bio-Fab Research
OriGene
Prospec-Tany Technogene
Addgene
Protein Ark
Protomnis
RD-Biotech
Charles River
听
听
*If Applicable.
